Rikard Rodén

MediRox AB engages in developing, manufacturing and marketing of control plasmas and diagnostic reagents for coagulation analytes. Its products include PT, APTT, AT, TT, Fib Clauss and D-Dimer within the field of haemostasis. The company was founded in 1998 and is headquartered in Nykoping, Sweden.

Nordic Biomarker AB is a Swedish manufacturer of routine and specialty reagents for coagulation analysis. Nordic Biomarker is based in Umeå, SE. The Swedish company offers CE-marked kits and OEM products, available in vials or bulk, intended for calibration of MRX D-dimer assays run on coagulation analyzers, in ng/mL DDU. The company's FDP reagent is optimized for assay with coagulation analyzers at 500-700 nm, where 550 nm and 575 nm is most commonly used. The company was founded in 2007 by Gunnar Pohl and Göran Aronsson, and the CEO is Rikard Rodén.